A Phase 2a Study to Evaluate the Effect of Rilapladib (SB-659032) in Alzheimer's Disease

Clinical trial NCT01428453 · COMPLETED

Trial details

NCT number: NCT01428453
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2011-10-01
Primary completion: 2013-02-04
Enrollment: 124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.